Skip to content

Browse Protocols

Wrote one of these methods? Find yours by DOI and review the entry.

Find your method
934 protocols found
934 protocols found
GASTRIC
Publication-derived

Signet-Ring Cell Carcinoma Gastric Tumouroids (GS-DS-19)

Source Li et al., 2019 · Fudan University Shanghai Cancer Center · DOI

Duration: 120 days Cell source: Patient-Derived Carcinoma (Signet-ring cell carcinoma, primary colon tumor with ovarian metastases) Full SOP · 8 phases · QC included
Drug screening
GS-DS-19 Full SOP with Academic or a plan
BRAIN
Publication-derived

Frontotemporal Dementia Cortical Organoids (BN-DS-25)

Source Cordella et al., 2025 · Sapienza University of Rome · DOI

Duration: 100 days Cell source: Human iPSC Full SOP · 4 phases · QC included
Disease modelling
BN-DS-25 Full SOP with Academic or a plan
RETINA
Publication-derived

Retinal Organoids for Disease and Development (2018) (RT-DS-18)

Source Fligor et al., 2018 · Department of Biology, Indiana University Purdue University Indianapolis · DOI

Duration: 80 days Cell source: Human ESC (H9), Human iPSC (miPS2), CRISPR-engineered hPSC lines (A81-H7, E4-H7) Full SOP · 9 phases · QC included
Disease modelling
RT-DS-18 Full SOP with Academic or a plan
BLADDER
Publication-derived

Bladder Cancer Tumouroids for Drug Screening

Source Lee et al., 2018 · Columbia University Medical Center · DOI

Duration: 50 days Cell source: Patient-Derived Bladder Tumor (Urothelial Carcinoma) Full SOP · 7 phases · QC included
Drug screening
Full SOP with Academic or a plan
BRAIN
Publication-derived

Medulloblastoma Brain Organoids for Drug Screening (BN-DS-19)

Source Frisira et al., 2019 · Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London · DOI

Duration: 28 days Cell source: Patient-Derived iPSC (Medulloblastoma G3/G4) Full SOP · 10 phases · QC included
Drug screening
BN-DS-19 Full SOP with Academic or a plan
BRAIN
Publication-derived

COVID-19 Choroid Plexus Organoids for Infection Studies (BN-DS-20)

Source Pellegrini et al., 2020 · MRC Laboratory of Molecular Biology, Cambridge Biomedical Campus, Cambridge, UK · DOI

Duration: 55 days Cell source: Human ESC (H9) Full SOP · 9 phases · QC included
Disease modelling
BN-DS-20 Full SOP with Academic or a plan
BRAIN
Publication-derived

Brain Organoids for Drug Screening with Gene Editing (BN-DS-24)

Source Hendriks et al., 2024 · Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW), Utrecht, the Netherlands · DOI

Duration: 30 days Cell source: Human fetal neural stem cells and progenitors (GW12-15) Full SOP · 3 phases · QC included
Drug screening
BN-DS-24 Full SOP with Academic or a plan
GASTRIC
Publication-derived

Gastric Organoids for Disease Modelling (2015) (GS-DS-15)

Source Huch et al., 2015 · Wellcome Trust/Cancer Research UK Gurdon Institute, University of Cambridge · DOI

Duration: 34 days Cell source: Human ESC; Human iPSC Full SOP · 3 phases · QC included
Disease modelling
GS-DS-15 Full SOP with Academic or a plan
LIVER
Publication-derived

Hepatoblastoma Liver Tumouroids (2024) (LV-DS-24)

Source Wu et al., 2024 · Stanford University School of Medicine · DOI

Duration: 3 days Cell source: Patient-Derived Tumor (Hepatoblastoma) Full SOP · 11 phases · QC included
Disease modelling
LV-DS-24 Full SOP with Academic or a plan
INTESTINAL
Publication-derived

Intestinal Organoids for Regeneration and Disease Modelling (IN-DS-18)

Source Fujii et al., 2018 · Keio University School of Medicine · DOI

Duration: 182 days Cell source: Human intestinal crypts and small intestinal organoids Full SOP · 5 phases · QC included
Disease modelling
IN-DS-18 Full SOP with Academic or a plan
BRAIN
Publication-derived

Ischaemic Stroke Cerebral Organoids for Transplantation (BN-DS-20)

Source Wang et al., 2020 · Second Military Medical University / Naval Medical University, Shanghai, China · DOI

Duration: 55 days Cell source: Human ESC (H1) Full SOP · 11 phases · QC included
Disease modelling
BN-DS-20 Full SOP with Academic or a plan
INTESTINAL
Publication-derived

Cystic Fibrosis Intestinal Organoids for Disease Modelling (IN-DS-20)

Source Fleischer et al., 2020 · Consejo Superior de Investigaciones Científicas (CSIC/IMEDEA) · DOI

Duration: 95 days Cell source: Patient-Derived iPSC (Cystic Fibrosis p.F508del) Full SOP · 16 phases · QC included
Disease modelling
IN-DS-20 Full SOP with Academic or a plan
BRAIN
Publication-derived

Schizophrenia Cerebral Organoids for Developmental Studies (BN-DS-21)

Source Notaras et al., 2021 · Center for Neurogenetics, Feil Family Brain and Mind Research Institute, Weill Cornell Medical College, Cornell University · DOI

Duration: 40 days Cell source: Patient-Derived iPSC (Schizophrenia), Human iPSC (Control) Full SOP · 8 phases · QC included
Disease modelling
BN-DS-21 Full SOP with Academic or a plan
INTESTINAL
Publication-derived

Colorectal Cancer Colonic Organoids for Long-Term Culture (IN-DS-11)

Source Sato et al., 2011 · Hubrecht Institute, KNAW and University Medical Centre Utrecht · DOI

Duration: 30 days Cell source: Human iPSC, Patient-Derived intestinal crypts (colon cancer, Barrett's esophagus) Full SOP · 6 phases · QC included
Drug screening
IN-DS-11 Full SOP with Academic or a plan
LIVER
Publication-derived

Steatohepatitis Liver Organoids for Developmental Studies (LV-DS-19)

Source Ouchi et al., 2019 · Cincinnati Children's Hospital Medical Center · DOI

Duration: 30 days Cell source: Human iPSC, Human ESC Full SOP · 5 phases · QC included
Disease modelling
LV-DS-19 Full SOP with Academic or a plan
INTESTINAL
Publication-derived

Colorectal Cancer Colonic Organoids (2016) (IN-CA-16)

Source Fujii et al., 2016 · Keio University School of Medicine, Department of Gastroenterology · DOI

Duration: 120 days Cell source: Patient-Derived Tissue (Colorectal Adenoma and Adenocarcinoma) Full SOP · 5 phases · QC included
Drug screening
IN-CA-16 Full SOP with Academic or a plan
BRAIN
Publication-derived

Zika Virus Infection-Induced Microcephaly Cerebral Organoids for Disease Modelling (BN-DS-16)

Source Dang et al., 2016 · University of California San Diego, Department of Pediatrics · DOI

Duration: 30 days Cell source: Human ESC (H9 hESC, WA09) Full SOP · 7 phases · QC included
Disease modelling
BN-DS-16 Full SOP with Academic or a plan
BRAIN
Publication-derived

Midbrain Organoids for Drug Screening in High-Throughput Format (BN-DS-21)

Source Boussaad et al., 2021 · Luxembourg Centre for Systems Biomedicine, University of Luxembourg & Luxembourg Institute of Health · DOI

Duration: 30 days Cell source: Human iPSC, Human Fibroblasts, Small Molecule-Derived Neural Progenitor Cells (smNPC) Full SOP · 7 phases · QC included
Drug screening
BN-DS-21 Full SOP with Academic or a plan
LIVER
Publication-derived

Hepatocellular Carcinoma Organoids (LV-CA-19)

Source Sun et al., 2019 · Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences · DOI

Duration: 60 days Cell source: Human iPSC-derived induced hepatocytes (hiHeps) from fibroblasts Full SOP · 8 phases · QC included
Disease modelling
LV-CA-19 Full SOP with Academic or a plan
RETINA
Publication-derived

Retinal Organoids for Disease Modelling (2020, No. 3) (RT-DS-20)

Source Döpper et al., 2020 · Institute of Human Genetics, University Hospital Essen, University of Duisburg-Essen · DOI

Duration: 152 days Cell source: Human ESC (H9 line) Full SOP · 8 phases · QC included
Disease modelling
RT-DS-20 Full SOP with Academic or a plan
BRAIN
Publication-derived

Schizophrenia and Major Depression Cortical 2D Cell Cultures (BN-DS-14)

Source Wen et al., 2014 · Johns Hopkins University School of Medicine · DOI

Duration: 42 days Cell source: Patient-Derived iPSC (Schizophrenia and Major Depression with DISC1 frameshift mutation) Full SOP · 10 phases · QC included
Disease modelling
BN-DS-14 Full SOP with Academic or a plan
BRAIN
Publication-derived

Midbrain Organoids for Drug Screening and Toxicity Testing (BN-TX-21)

Source Renner et al., 2021 · Department for Cell and Developmental Biology, Max Planck Institute for Molecular Biomedicine, Münster, Germany · DOI

Duration: 56 days Cell source: Human iPSC-derived small molecule neural precursor cells (smNPCs) Full SOP · 7 phases · QC included
Drug screening
BN-TX-21 Full SOP with Academic or a plan
BRAIN
Publication-derived

Malignant Brain Tumour Organoids (BN-DS-22)

Source Chen et al., 2022 · China Medical University Hospital, Taichung, Taiwan · DOI

Duration: 28 days Cell source: Patient-derived surgical tumor tissue (glioma, meningioma, lymphoma, and brain metastases) Full SOP · 6 phases · QC included
Drug screening
BN-DS-22 Full SOP with Academic or a plan
LIVER
Publication-derived

Liver Organoids for Drug Screening (2021) (LV-DI-21)

Source Don, 2021 · University of Cambridge, Department of Physiology, Development and Neuroscience · DOI

Duration: 35 days Cell source: Human hepatic ductal cells and primary human hepatocytes Full SOP · 4 phases · QC included
Drug screening
LV-DI-21 Full SOP with Academic or a plan